Table 2.
Differences between baseline and the 30th and 120th days of SGRQ scores and its components in the study groups.
| SGRQ component |
By day 30
|
By day120
|
||||
|---|---|---|---|---|---|---|
| Placebo | Vitamin D | p-value | Placebo | Vitamin D | p-value | |
| Symptom score | 10.71 ± 6.44 | 15.18 ± 8.85 | 0.050 | 12.26 ± 7.81 | 19.45 ± 8.94 | 0.001* |
| Activity score | 1.88 ± 3.73 | 4.11 ± 3.43 | 0.008* | 2.69 ± 3.96 | 8.11 ± 6.13 | 0.001* |
| Impact score | 2.61 ± 3.20 | 3.77 ± 3.82 | 0.40 | 2.13 ± 4.39 | 5.76 ± 4.62 | 0.007* |
| Total score | 3.73 ± 1.84 | 5.69 ± 2.13 | 0.0003* | 3.99 ± 2.19 | 8.66 ± 3.32 | 0.0001* |
Significant improvement in vitamin D group versus placebo (p < 0.05)